Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(16 sites)
United States
Nkarta Investigational Site, Little Rock, Arkansas Nkarta Investigational Site, Gainesville, Florida Nkarta Investigational Site, Miami, Florida Nkarta Investigational Site, Plantation, Florida Nkarta Investigational Site, Tampa, Florida Nkarta Investigational Site, Atlanta, Georgia Nkarta Investigational Site, Chicago, Illinois Nkarta Investigational Site, New Orleans, Louisiana Nkarta Investigational Site, Worcester, Massachusetts Nkarta Investigational Site, Ann Arbor, Michigan Nkarta Investigational Site, New York, New York Nkarta Investigational Site, Stony Brook, New York Nkarta Investigational Site, Syracuse, New York Nkarta Investigational Site, Dallas, Texas Nkarta Investigational Site, Houston, Texas Puerto Rico
Nkarta Investigational Site, Manati